Oregon
Oregon
Providence reaches out to begin scheduling mediation
Jan. 11, 2025 News Release: With record numbers of caregivers returning to work, our ministries are now in a position to discuss resuming mediated negotiation sessions.
Top 5 things to know about getting care during ONA strike
Here’s what you need to know about getting care at Providence hospitals and clinic during the Oregon Nurses Association strikes that start Friday, January 10.
Protecting your access to health care is our priority
Jan. 8, 2025 News Release: We have negotiated in good faith to reach agreements with Oregon Nurses Association (ONA), but these strikes will compromise access to care
Providence warns union strike creates "significant risk" for health care in Oregon
Jan. 7, 2025 News Release: Providence informs state leaders the open-ended strike planned by leaders of the Oregon Nurses Association puts health care access at “significant risk” in the state.
Providence is given notice by ONA to strike
Dec. 30, 2024 News Release: Providence is given notice by ONA to strike at multiple Oregon ministries, including our eight acute hospitals
A year to remember: Advancements, recognition and transitions
Catch the 2024 highlights from Providence Cancer Institute in this year-end recap focused on research advancements, caregiver recognition and community engagement.
CAR T cell-therapy, hope and healing: Dean’s story
Discover how Dean Lookingbill’s battle with lymphoma led him to CAR T-cell therapy at Providence Cancer Institute.
Two clinical trials for solid tumor cancers take different approaches to stop growth
Two global studies open at Providence Cancer Institute will evaluate combinations of medications to help stop or slow the growth of cancer in solid tumors.
Comprehensive Genomic Profiling leads to better patient outcomes, new joint study says
Real-world data from Providence, Illumina and Microsoft Research finds cancer patients with early genomic testing received better precision treatment, underlines urgency to become standard practice
Leadership change at Providence Cancer Institute, #FINISHCANCER goal remains
R. Bryan Bell, M.D., D.D.S., FACS, FRCS(Ed) has accepted the roles of executive medical director of Providence Cancer Institute and director of the Earle A. Chiles Research Institute.
2024 SITC Meeting: A glimpse of recent advancements in immunotherapy
The annual SITC meeting brings together cancer immunotherapy researchers with a goal to advance science, discover breakthroughs and educate the world on cancer immunotherapy.
Harnessing CAR T-cell therapy: A new study for indolent B-cell non-Hodgkin lymphoma
New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.
New studies test immunotherapy to boost breast cancer treatment and prevent return
Explore promising clinical trials at Providence Cancer Institute that are investigating immunotherapy for early-stage TNBC and high-risk, HR-positive breast cancer.
Attend a free virtual symposium on melanoma, Oct. 25
Providence Cancer Institute in partnership with AIM at Melanoma present a free online event designed to educate and empower patients and care partners affected by melanoma.
Prostate cancer study includes a tumor test to personalize treatment
A new study approach reflects a deeper understanding of cancer at the molecular level and marks a shift away from one-size-fits-all treatments.
Stay healthy and on your feet with free fall prevention events
Free educational presentations from Providence Senior Health are taking place in September in Beaverton, Hillsboro, Seaside and Medford. See the schedule and registration information.
Meet physician scientist, Dr. Allie Grossmann
Dr. Allie Grossmann’s new lab at Earle A. Chiles Research Institute is focused on understanding how tumors communicate with their environment, grow, survive and spread.
‘Exploring the end of life creates opportunities to celebrate life’
Hospice volunteers offer respite to family members, care for patients at the end of their lives and help people navigate grief. Learn about their service and how to volunteer.
‘Why we run’ – hear from Providence’s Hood To Coast teams
“For my patients.” “For my friend’s daughter.” “For the challenge.” “For the cure.” Providence runners and walkers share why they’re doing the relay – and helping raise funds to #FINISHCANCER.
Dr. Walter Urba announces retirement from Providence
Dr. Walter Urba, a pioneer and key figure in the development of immunotherapy, will retire from Providence Cancer Institute at the end of year.
